Authors: Grohmann, U Fallarino, F Silla, S Bianchi, R Belladonna, ML Vacca, C Micheletti, A Fioretti, MC Puccetti, P

Citation: U. Grohmann et al., CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells, J IMMUNOL, 166(1), 2001, pp. 277-283

Authors: Grohmann, U Bianchi, R Belladonna, ML Silla, S Fallarino, F Fioretti, MC Puccetti, P

Citation: U. Grohmann et al., IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha(-) dendritic cells via potentiation of the CD8 alpha(+) subset, J IMMUNOL, 165(3), 2000, pp. 1357-1363

Authors: Grohmann, U Van Snick, J Campanile, F Silla, S Giampietri, A Vacca, C Renauld, JC Fioretti, MC Puccetti, P

Citation: U. Grohmann et al., IL-9 protects mice from gram-negative bacterial shock: Suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10, J IMMUNOL, 164(8), 2000, pp. 4197-4203

Authors: Silla, S Fallarino, F Boon, T Uyttenhove, C

Citation: S. Silla et al., Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPL, EUR CYTOKIN, 10(2), 1999, pp. 181-189

Authors: Grohmann, U Belladonna, ML Bianchi, R Orabona, C Silla, S Squillacioti, G Fioretti, MC Puccetti, P

Citation: U. Grohmann et al., Immunogenicity of tumor peptides: importance of peptide length and stability of peptide MHC class II complex, CANCER IMMU, 48(4), 1999, pp. 195-203

Authors: Grohmann, U Bianchi, R Belladonna, ML Vacca, C Silla, S Ayroldi, E Fioretti, MC Puccetti, P

Citation: U. Grohmann et al., IL-12 acts selectively on CD8 alpha(-) dendritic cells to enhance presentation of a tumor peptide in vivo, J IMMUNOL, 163(6), 1999, pp. 3100-3105